B2M and colorectal cancer: Although there is no study so far investigating this topic in EPs and EPCs, studies with colorectal cancers have revealed that in tumours with high microsatellite-instability, the expression of HLA-A, HLA-B, and HLA-C were decreased and incidence of mutations in B2M were increased44.